Department of Medicine Archive — Page 103 of 119
-
October 1, 2015
Major grant to transform region’s clinical practices
Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs. -
October 1, 2015
Many hands help make wedding dream come true
Their wedding date was just weeks away when Caleb Hanby and his fiancée Bethany Davidson rushed to Vanderbilt University Medical Center last Thursday. -
September 30, 2015
Reduced-nicotine cigarettes decreased dependence and frequency of smoking: NEJM study
Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine. -
September 17, 2015
Heart repair factor
A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack. -
September 17, 2015
Study shows lower systolic BP targets reduce death risk
The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older. -
September 10, 2015
Grants spur effort to add genetic data to EMR
Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records. -
September 10, 2015
Initiative seeks to bolster ‘rediscovery research’
The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.